FTC Says To Ignore Its Previous Guidance About PBMs
The Federal Trade Commission is in the process of reevaluating its stance on pharmacy benefit managers and amid its ongoing study of their role in the marketplace, it's warning the public...To view the full article, register now.
Already a subscriber? Click here to view full article